Search bioRxiv⌕ Search

Biology subjects

Ballotto, L.

Publications and source records attributed to Ballotto, L..

2 recordsLinked to original sources

Evolutionary divergence of LRRK2 interaction domains contributes to human- and mouse-specific protein interaction networks

Leucine-rich repeat kinase 2 (LRRK2) is a complex multidomain protein whose catalytic and protein-protein interaction domains regulate a wide range of cellular processes. To investigate whether evolutionary divergence of these domains contributes to species-specific differences in LRRK2 biology, we combined phylogenetic, sequence, interactome and structural analyses of human and mouse LRRK2. Phylogenetic analysis revealed that the catalytic core predates the acquisition of the N-terminal and C-terminal protein-protein interaction domains during LRRK2 evolution. Accordingly, despite the high overall sequence similarity between human and mouse LRRK2, sequence divergence was not uniformly distributed across the protein but was concentrated within protein-protein interaction domains, whereas the catalytic ROC-COR- kinase core displayed markedly higher conservation. Consistent with this pattern, comparison of curated human and mouse interactomes revealed substantial differences in protein interaction networks and associated biological pathways. Structural modelling of a subset of interactors further showed that predicted interaction interfaces are enriched for residues that differ between the two species, providing a structural rationale for altered interaction specificity. Together, these findings support the view that evolutionary divergence of LRRK2 protein-protein interaction domains contributes to species-specific interactome organization. These results provide an evolutionary framework for interpreting differences between human and mouse LRRK2 and highlight the importance of considering species-specific interaction networks when translating findings from experimental models.

bioinformatics↗

Nuclear ASC speck formation in microglia is associated with inflammasome priming and is exacerbated in LRRK2-G2019S Parkinson disease

Neuroinflammation is increasingly recognized as a central pathological mechanism in Parkinsons disease (PD), a progressive neurodegenerative disorder characterized by the selective loss of dopaminergic neurons and variety of motor and non-motor symptoms. The NOD-like receptor family pyrin domain-containing 3 (NLRP3) inflammasome and its adaptor protein ASC play a critical role in initiating and maintaining inflammatory responses in the central nervous system. Although its acute activation is beneficial for host defense and homeostasis, chronic activation of the inflammasome has been associated with the pathogenesis of PD. Another key contributor to neuroinflammation is the leucine-rich repeat kinase 2 (LRRK2), particularly the G2019S mutation associated with PD, which has been shown to exacerbate inflammatory signaling in microglia and peripheral immune cells. However, the interaction between LRRK2 and the NLRP3 inflammasome pathway remains poorly understood. In this study, we investigated the role of LRRK2-G2019S in the priming and activation dynamics of the NLRP3 inflammasome using mouse primary microglia and human monocyte-derived microglia-like cells (hMDMi). We observed that LRRK2-G2019S microglia exhibit increased expression of NLRP3 under basal conditions and spontaneous formation of ASC specks within the nucleus, an unexpected subcellular location not previously reported in microglia. Interestingly, nuclear ASC specks also formed in wild-type microglia and hMDMi after lipopolysaccharide (LPS) priming but only progressed to cytosolic ASC specks and interleukin-1{beta} release after subsequent exposure to canonical NLRP3 activators. These findings suggest that nuclear ASC specks may represent a primed state of inflammasome activation and propose a novel cellular phenotype associated with LRRK2-G2019S. Altogether, our results reveal a new layer of inflammasome regulation in microglia and implicate LRRK2-G2019S in the promotion of a pro-inflammatory state, which may predispose to chronic neuroinflammation in PD. These findings advance our understanding of glial immune regulation and highlight potential therapeutic targets in PD.

physiology↗